(Q37820898)

English

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics

scientific article published on 14 December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

Europe PubMed Central

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

gastroenterology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Salvatore Cucchiara

2

0 references

William Jeffery Sandborn

7

object named as

William J Sandborn

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

author name string

Uma Mahadevan

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Jeffrey S Hyams

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Flavio Steinwurz

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

F Nuti

5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Simon P L Travis

6

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Jean-Frederio Colombel

8

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

language of work or name

0 references

publication date

14 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

106

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

214-23; quiz 224

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Inflammatory bowel disease: a controlled study of late pregnancy outcome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Placental transport of immunoglobulin G.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab and semen quality in men with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab delays but does not avoid the need for surgery in treatment-resistant pediatric Crohn' disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (remicade) in severe pediatric crohn disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab dependency in pediatric Crohn's disease: long-term follow-up of an unselected cohort

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Use of infliximab in the treatment of Crohn's disease in children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab therapy in pediatric Crohn's pouchitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Use of infliximab in pediatric patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab dependency in a national cohort of children with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Efficacy of infliximab in pediatric Crohn's disease: a randomized multicenter open-label trial comparing scheduled to on demand maintenance therapy

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Safety and efficacy of adalimumab in pediatric patients with Crohn disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Short-term response to adalimumab in childhood inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Efficacy of adalimumab in moderate-to-severe pediatric Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Natalizumab therapy for moderate to severe Crohn disease in adolescents

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab as a novel therapy for pediatric ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab in pediatric ulcerative colitis: two-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab efficacy in pediatric ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab for pediatric ulcerative colitis: a retrospective Italian multicenter study.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Outcome following infliximab therapy in children with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Height and occupational success: a review and critique

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Psychological and emotional development, intellectual capabilities, and body image in short normal children.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Growth retardation in pediatric Crohn's disease: pathogenesis and interventions

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Retrospective case review of pediatric patients with uveitis treated with infliximab

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab for juvenile idiopathic arthritis-associated uveitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Adalimumab in the therapy of uveitis in childhood

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infections and IBD.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Risk factors for opportunistic infections in patients with inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Risks and benefits of infliximab for the treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Pediatric inflammatory bowel diseases and the risk of lymphoma: should we revise our treatment strategies?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infusion reactions to infliximab in children and adolescents: frequency, outcome and a predictive model

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab therapy in children and adolescents with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: a critical systematic review

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Guidelines for immunizations in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Identifiers

10.1038/AJG.2010.464

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

release_7wkkffge3zeafbdk2yaykheriy

1 reference

https://api.fatcat.wiki/v0/release/7wkkffge3zeafbdk2yaykheriy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37820898&oldid=2097500237"